Form 8-K - Current report:
SEC Accession No. 0001641172-25-017046
Filing Date
2025-06-30
Accepted
2025-06-30 07:30:55
Documents
12
Period of Report
2025-06-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44679
  Complete submission text file 0001641172-25-017046.txt   213976

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mira-20250630.xsd EX-101.SCH 3047
3 XBRL LABEL FILE mira-20250630_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE mira-20250630_pre.xml EX-101.PRE 22380
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3813
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
Type: 8-K | Act: 34 | File No.: 001-41765 | Film No.: 251088756
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)